Nektar Therapeutics NKTR
38.48 USD +0.72 (+1.91%)
At closeNov 4, 2026, 5:30 PM EST
38.48 0.00 0.00%
After hours · Nov 4, 5:30 PM ET
37.50 Day range 39.19
33.40 52-week range 109.00
- YTD
- -8.99%
- 1 year
- -31.31%
Analyst view
Consensus: buy
Buy
Price target (mean) 133.08 +245.9% upside
Now 38.48
- Target (low)
- 50.00
- Target (mean)
- 133.08
- Target (high)
- 192.00
Ratings (0m) 15 11 buy · 4 hold · 0 sell
- Strong buy1
- Buy10
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.07 | -3.07 – -1.71 | -1.87 | -10.7% | 10.40M | -11.8% | 15 |
| Next quarter | -2.76 | -3.53 – -2.14 | -1.78 | -54.9% | 10.47M | -52.0% | 15 |
| Current year | -8.08 | -9.63 – -6.89 | -9.73 | +16.9% | 41.82M | -24.3% | 15 |
| Next year | -10.50 | -20.03 – -4.10 | -8.08 | -29.9% | 53.42M | +27.7% | 15 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | UBS | Initiated | — | Neutral |
| Oct 12, 2026 | Leerink Partners | Initiated | — | Outperform |
| Oct 9, 2026 | BTIG | Reiterated | Buy | Buy |
| Oct 9, 2026 | Raymond James | Initiated | — | Market Perform |
| Oct 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 28, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 25, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 23, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Sep 16, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 9, 2026 | BTIG | Reiterated | Buy | Buy |
| Jul 22, 2026 | Canaccord Genuity | Initiated | — | Buy |
| May 11, 2026 | Wedbush | Maintained | Neutral | Neutral |
| May 8, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Apr 21, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 21, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Apr 20, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 20, 2026 | BTIG | Maintained | Buy | Buy |
| Mar 24, 2026 | Wedbush | Initiated | — | Neutral |
| Mar 17, 2026 | TD Cowen | Initiated | — | Buy |
| Mar 16, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 23, 2026 | B. Riley Securities | Reiterated | Buy | Buy |
| Feb 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 10, 2026 | BTIG | Maintained | Buy | Buy |
| Jan 29, 2026 | BTIG | Reiterated | Buy | Buy |
| Dec 16, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 16, 2025 | BTIG | Maintained | Buy | Buy |
| Nov 26, 2025 | Citigroup | Initiated | — | Buy |
| Nov 26, 2025 | Jefferies | Maintained | Buy | Buy |
| Sep 23, 2025 | B. Riley Securities | Maintained | Buy | Buy |
| Sep 19, 2025 | BTIG | Reiterated | Buy | Buy |